新西兰2014-2016年人与禽类耐氟喹诺酮和四环素空肠弯曲菌ST6964基因组分析
研究分析了2014年新西兰北岛3家禽类供应公司禽类及人类感染中同时出现的耐四环素和氟喹诺酮空肠弯曲菌ST6964。基因组分析显示该谱系分化为两个主要分支,均与人类感染相关, accessory基因组进化涉及质粒、噬菌体插入和自然转化。结果表明耐药克隆在新西兰的出现和快速传播,强调需持续开展禽类与人类弯曲菌监测。
要点
- ST6964同时耐四环素和氟喹诺酮,2014年在新西兰禽类与人类中同时出现。
- 该谱系分两个主要分支,分别与禽类公司A/B和公司C相关,均致人类感染。
- accessory基因组进化涉及质粒、噬菌体插入和自然转化,需持续监测。
核心结论
- 耐四环素和氟喹诺酮的空肠弯曲菌ST6964在新西兰禽类与人类中同时出现并快速传播, accessory基因组进化活跃,需持续监测。
研究设计与样本
- 对2014年新西兰北岛3家禽类供应公司禽类及人类感染中出现的空肠弯曲菌ST6964进行基因组分析。
主要发现
- ST6964谱系在新西兰此前未识别,耐四环素和氟喹诺酮。
- 基因组分析显示该谱系分化为两个主要分支,均与人类感染相关,一个与禽类公司A和B相关,另一个与公司C相关。
- accessory基因组进化与质粒、噬菌体插入和自然转化相关。
- 推测tetO基因和噬菌体在接合后插入染色体,留下残余质粒,该质粒从公司C分离株中丢失。
临床怎么用
- 临床应关注耐氟喹诺酮和四环素的空肠弯曲菌感染,尤其在禽类相关暴露后。
- 需持续开展禽类与人类的弯曲菌监测以追踪耐药克隆传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2014, antimicrobial drug-resistant Campylobacter jejuni sequence type 6964 emerged contemporaneously in poultry from 3 supply companies in the North Island of New Zealand and as a major cause of campylobacteriosis in humans in New Zealand. This lineage, not previously identified in New Zealand, was resistant to tetracycline and fluoroquinolones. Genomic analysis revealed divergence into 2 major clades; both clades were associated with human infection, 1 with poultry companies A and B and the other with company C. Accessory genome evolution was associated with a plasmid, phage insertions, and natural transformation. We hypothesize that the tetO gene and a phage were inserted into the chromosome after conjugation, leaving a remnant plasmid that was lost from isolates from company C. The emergence and rapid spread of a resistant clone of C. jejuni in New Zealand, coupled with evolutionary change in the accessory genome, demonstrate the need for ongoing Campylobacter surveillance among poultry and humans.
引用
- French NP, Zhang J, Carter GP, et al. Genomic Analysis of Fluoroquinolone- and Tetracycline-Resistant Campylobacter jejuni Sequence Type 6964 in Humans and Poultry, New Zealand, 2014-2016. Emerg Infect Dis. 2019. PMID: 31742539. doi:10.3201/eid2512.190267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。